{"accidental exposure to product": 7.57, "adrenal insufficiency": 2.03, "adverse drug reaction": 3.63, "aphonia": 2.42, "asphyxia": 4.25, "asthma": 31.36, "asthmatic crisis": 77.56, "atelectasis": 3.3, "back pain": 2.29, "bedridden": 2.14, "blood immunoglobulin e increased": 5.57, "blood lactic acid increased": 11.02, "blood potassium decreased": 3.55, "blood test abnormal": 2.64, "breath sounds abnormal": 27.07, "bronchial obstruction": 17.55, "bronchial wall thickening": 31.2, "bronchiectasis": 10.0, "bronchitis": 5.01, "bronchopulmonary aspergillosis allergic": 34.87, "bronchospasm": 3.99, "cardiac operation": 2.5, "chest discomfort": 3.04, "chest x-ray abnormal": 17.29, "choking": 4.38, "choking sensation": 2.59, "chronic obstructive pulmonary disease": 2.71, "chronic sinusitis": 15.78, "circumstance or information capable of leading to medication error": 3.06, "condition aggravated": 4.33, "coronavirus infection": 10.91, "coronavirus test positive": 42.76, "cough": 4.25, "cystitis": 3.2, "decreased immune responsiveness": 2.48, "disease recurrence": 3.12, "drug effective for unapproved indication": 2.96, "dysphonia": 2.26, "dyspnoea": 3.54, "dyspnoea exertional": 4.13, "ear pruritus": 17.43, "eczema": 3.91, "emphysema": 3.27, "endotracheal intubation": 3.58, "eosinophil count abnormal": 56.19, "eosinophil count decreased": 25.64, "eosinophil count increased": 15.78, "eosinophilia": 3.3, "eosinophilic granulomatosis with polyangiitis": 27.87, "exposure via skin contact": 93.47, "eye pruritus": 3.75, "fear of injection": 12.89, "forced expiratory volume decreased": 11.34, "full blood count abnormal": 35.57, "hospitalisation": 6.79, "ill-defined disorder": 4.14, "illness": 2.67, "immune system disorder": 2.53, "inappropriate schedule of product administration": 4.1, "increased bronchial secretion": 6.27, "influenza": 2.11, "injection site discomfort": 2.84, "injection site urticaria": 3.08, "kidney infection": 3.04, "lacrimation increased": 2.4, "loss of personal independence in daily activities": 14.41, "lower respiratory tract infection": 4.89, "lung disorder": 3.76, "middle insomnia": 3.44, "multiple allergies": 11.35, "nasal congestion": 7.42, "nasal polyps": 97.85, "nasopharyngitis": 2.95, "obstructive airways disorder": 24.53, "oxygen saturation decreased": 2.88, "peak expiratory flow rate decreased": 39.99, "pharyngitis": 3.18, "platelet count increased": 4.74, "pneumonia": 3.56, "pneumonia bacterial": 2.66, "polymyalgia rheumatica": 2.74, "polyp": 5.32, "product availability issue": 8.74, "product complaint": 6.76, "product dose omission issue": 10.47, "product use in unapproved indication": 2.09, "productive cough": 14.06, "pulmonary congestion": 5.21, "pulmonary function test abnormal": 52.61, "pulmonary function test decreased": 4.92, "pulmonary mass": 3.94, "quality of life decreased": 3.43, "respiratory disorder": 4.12, "respiratory symptom": 10.85, "respiratory tract congestion": 5.02, "respiratory tract infection": 4.46, "rhinitis": 2.86, "rhinitis allergic": 15.07, "rhinorrhoea": 3.23, "scratch": 3.9, "seasonal allergy": 5.82, "secretion discharge": 11.54, "sinus congestion": 3.62, "sinus disorder": 3.04, "sinusitis": 6.95, "skin lesion": 2.31, "sleep disorder due to a general medical condition": 103.48, "sneezing": 5.58, "social problem": 18.07, "spinal operation": 2.4, "sputum discoloured": 25.39, "surgery": 3.12, "symptom recurrence": 8.95, "therapeutic product effect incomplete": 19.18, "therapeutic response unexpected": 2.2, "therapy cessation": 5.62, "therapy interrupted": 12.14, "upper respiratory tract infection": 2.15, "upper-airway cough syndrome": 24.78, "use of accessory respiratory muscles": 17.51, "vasculitis": 4.11, "viral infection": 3.01, "wheezing": 28.46, "wrong technique in device usage process": 13.46}